These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 7346180)
41. Nimodipine in migraine prophylaxis. Ansell E; Fazzone T; Festenstein R; Johnson ES; Thavapalan M; Wilkinson M; Wozniak I Cephalalgia; 1988 Dec; 8(4):269-72. PubMed ID: 3064919 [TBL] [Abstract][Full Text] [Related]
42. Nifedipine in migraine and tension headache: a randomised double blind crossover study. Shukla R; Garg RK; Nag D; Ahuja RC J Assoc Physicians India; 1995 Nov; 43(11):770-2. PubMed ID: 8773038 [TBL] [Abstract][Full Text] [Related]
43. Selection of patients for clinical drug trials in migraine. Solomon S Neuroepidemiology; 1987; 6(4):164-71. PubMed ID: 3317096 [TBL] [Abstract][Full Text] [Related]
44. Central effects of drugs used in migraine prophylaxis evaluated by visual evoked potentials. Diener HC; Scholz E; Dichgans J; Gerber WD; Jäck A; Bille A; Niederberger U Ann Neurol; 1989 Feb; 25(2):125-30. PubMed ID: 2645824 [TBL] [Abstract][Full Text] [Related]
45. Intravenous dexamethasone vs placebo as adjunctive therapy to reduce the recurrence rate of acute migraine headaches: a multicenter, double-blinded, placebo-controlled randomized clinical trial. Donaldson D; Sundermann R; Jackson R; Bastani A Am J Emerg Med; 2008 Feb; 26(2):124-30. PubMed ID: 18272089 [TBL] [Abstract][Full Text] [Related]
46. Acupuncture in the prophylactic treatment of migraine headaches: pilot study. Lenhard L; Waite PM N Z Med J; 1983 Aug; 96(738):663-6. PubMed ID: 6576263 [TBL] [Abstract][Full Text] [Related]
47. Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study. Diener HC; Bussone G; Van Oene JC; Lahaye M; Schwalen S; Goadsby PJ; Cephalalgia; 2007 Jul; 27(7):814-23. PubMed ID: 17441971 [TBL] [Abstract][Full Text] [Related]
48. [Antidepressants in migraine prophylaxis]. Nagata E Brain Nerve; 2009 Oct; 61(10):1131-4. PubMed ID: 19882939 [TBL] [Abstract][Full Text] [Related]
49. Botulinum toxin type-a in the prevention of migraine: a double-blind controlled trial. Vo AH; Satori R; Jabbari B; Green J; Killgore WD; Labutta R; Campbell WW Aviat Space Environ Med; 2007 May; 78(5 Suppl):B113-8. PubMed ID: 17547312 [TBL] [Abstract][Full Text] [Related]
50. Botulinum toxin type A (BOTOX) for treatment of migraine headaches: an open-label study. Binder WJ; Brin MF; Blitzer A; Schoenrock LD; Pogoda JM Otolaryngol Head Neck Surg; 2000 Dec; 123(6):669-76. PubMed ID: 11112955 [TBL] [Abstract][Full Text] [Related]
51. Economic burden of transformed migraine: results from the American Migraine Prevalence and Prevention (AMPP) Study. Munakata J; Hazard E; Serrano D; Klingman D; Rupnow MF; Tierce J; Reed M; Lipton RB Headache; 2009 Apr; 49(4):498-508. PubMed ID: 19245386 [TBL] [Abstract][Full Text] [Related]
52. Propranolol in the treatment of acute migraine attacks. Banerjee M; Findley L Cephalalgia; 1991 Sep; 11(4):193-6. PubMed ID: 1742775 [TBL] [Abstract][Full Text] [Related]
53. [Prevention of migraine with flunarizine and acetylsalicylic acid. A double-blind study]. Pothmann R Monatsschr Kinderheilkd; 1987 Sep; 135(9):646-9. PubMed ID: 3313023 [TBL] [Abstract][Full Text] [Related]
54. Comparison of the effect of topiramate and sodium valporate in migraine prevention: a randomized blinded crossover study. Shaygannejad V; Janghorbani M; Ghorbani A; Ashtary F; Zakizade N; Nasr V Headache; 2006 Apr; 46(4):642-8. PubMed ID: 16643559 [TBL] [Abstract][Full Text] [Related]
57. Clonidine and childhood migraine: a pilot and double-blind study. Sills M; Congdon P; Forsythe I Dev Med Child Neurol; 1982 Dec; 24(6):837-41. PubMed ID: 6218003 [No Abstract] [Full Text] [Related]